MPS Code: 0519/2022
About the course
Over the years, beta-blockers and calcium channel blockers have been the backbone of antianginal therapy, yet some patients continue to be symptomatic. Thus, second-line antianginal therapy is required to reduce angina attacks and nitroglycerin use. Upon completion of this module, participants will gain insights into the following aspects:
Professor Chee Kok Han
Senior Consultant Cardiologist
University Malaya Medical Centre
Who should participate:
Please read thoroughly & understand the module before attempting the assessment questions.
Terms & Conditions:
The modules/articles are best viewed with:
Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards-compliant browser may be required to view the modules.